A novel peptide nanomedicine for treatment of pancreatogenic diabetes.

  title={A novel peptide nanomedicine for treatment of pancreatogenic diabetes.},
  author={Amrita Banerjee and Hayat Onyuksel},
  journal={Nanomedicine : nanotechnology, biology, and medicine},
  volume={9 6},
UNLABELLED Pancreatogenic diabetes (PD) is a potentially fatal disease that occurs secondary to pancreatic disorders. The current anti-diabetic therapy for PD is fraught with adverse effects that can increase morbidity. Here we investigated the efficacy of novel peptide nanomedicine: pancreatic polypeptide (PP) in sterically stabilized micelles (SSM) for management of PD. PP exhibits significant anti-diabetic efficacy but its short plasma half-life curtails its therapeutic application. To… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
3 Extracted Citations
35 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 35 references

Novel, biocompatible, disease modifying nanomedicine of VIP for rheumatoid arthritis

  • V Sethi, I Rubinstein, A Kuzmis, H Kastrissios, J Artwohl, H. Onyuksel
  • Mol Pharm. 2012 Dec
  • 2012

Similar Papers

Loading similar papers…